
AI Coverage
about 10 hours ago
Radiology Roundup of FDA News: June 1 — June 79 days ago
Top Five Radiology Content in May 2026Latest News

Radiology Roundup of FDA News: June 1 — June 7

Diagnostic Imaging’s Weekly Scan: May 31 — June 6

PSMA PET Plays Key Role in Multinational Phase 3 Trial of Perioperative Apalutamide for PCa

FDA Clears AI Software for Automated Contouring in Radiation Oncology

Molecular Imaging in Focus: SNMMI: Can a New Total Body PET Scanner Slash Scan Times and Bolster Sensitivity?

Shorts










Podcasts
Videos
All News

In a recent interview, Phillip Kuo, MD, discussed new comparative multicenter prospective research, presented at the SNMMI conference, examining the urinary radioactivity of two PSMA PET radiotracers 18F-piflufolastat and 18F-flotufolastat.

Prior vaccination for prostate cancer-specific antigens was associated with more than double the rate of two-year overall survival in patients with mCRPC who were treated with 177Lu-PSMA-617, according to new research presented at the SNMMI conference.

Preliminary research findings, presented at the SNMMI conference, suggest that the alpha-emitting radioconjugate ATNM-400 may be a viable alternative for treating PCa that is resistant to androgen receptor pathway inhibitors (ARPIs).

Noting the potential for workload efficiencies in interpreting screening digital breast tomosynthesis (DBT) images, researchers found the use of slab reconstruction technology improved specificity without any impact on sensitivity or cancer detection rate.

Reportedly trained on thousands of cardiac ultrasound images, the Ejection Fraction (EF) AI tool provides automated measurement of left ventricular ejection fraction (LVEF) in seconds.

The AI-powered Elevate Plus reportedly facilitates standardization of routine ultrasound, improves scan time and bolsters image quality.

Emphasizing the capability to evaluate the spatiotemporal distribution of PET radiotracers, the MIM KineticID software may provide greater quantitative insights into oncologic, cardiovascular and neurological disease management.

For patients undergoing myocardial perfusion PET/CT, a deep learning model demonstrated greater than 83 percent AUCs for classifying those with low- and high-risk coronary artery calcium (CAC) burden, according to new research presented at the SNMMI conference.

In the latest episode of the Molecular Imaging in Focus series, Isabelle Boileau, PhD, discussed preliminary research, presented at the SNMMI conference, which suggests the utility of a novel tau PET imaging agent that may help detect chronic traumatic encephalopathy (CTE) in living patients.

Do you embrace challenges and change or settle and wallow in your diagnostic comfort zone?

For patients with oligometastatic prostate cancer detected with PSMA PET, researchers found that nearly 78 percent of these patients had negative findings on conventional imaging, according to a study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

In a recent interview, Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT, shared her perspectives on advocacy for nuclear medicine technologists, scope of practice challenges, theranostics and improving access to PET imaging in rural communities.

Catch up on the top radiology content of the past week.

The Cone-Beam CT (CBCT) Perfusion software reportedly provides CT-quality perfusion maps during neurointerventional procedures.

Catch up on the most-well viewed radiology content in May 2026.



























